ALGS
Price
$5.54
Change
+$0.04 (+0.73%)
Updated
Oct 2 closing price
Capitalization
34.59M
33 days until earnings call
Intraday BUY SELL Signals
ARVN
Price
$7.41
Change
-$0.02 (-0.27%)
Updated
Oct 2 closing price
Capitalization
491.05M
38 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALGS vs ARVN

ALGS vs ARVN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALGS vs. ARVN commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and ARVN is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ALGS vs ARVN: Fundamental Ratings
ALGS
ARVN
OUTLOOK RATING
1..100
2851
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9983
PRICE GROWTH RATING
1..100
7780
P/E GROWTH RATING
1..100
10058
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALGS's Valuation (14) in the null industry is somewhat better than the same rating for ARVN (78) in the Biotechnology industry. This means that ALGS’s stock grew somewhat faster than ARVN’s over the last 12 months.

ALGS's Profit vs Risk Rating (100) in the null industry is in the same range as ARVN (100) in the Biotechnology industry. This means that ALGS’s stock grew similarly to ARVN’s over the last 12 months.

ARVN's SMR Rating (83) in the Biotechnology industry is in the same range as ALGS (99) in the null industry. This means that ARVN’s stock grew similarly to ALGS’s over the last 12 months.

ALGS's Price Growth Rating (77) in the null industry is in the same range as ARVN (80) in the Biotechnology industry. This means that ALGS’s stock grew similarly to ARVN’s over the last 12 months.

ARVN's P/E Growth Rating (58) in the Biotechnology industry is somewhat better than the same rating for ALGS (100) in the null industry. This means that ARVN’s stock grew somewhat faster than ALGS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGSARVN
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 12 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 1 day ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (ALGS: $5.54 vs. ARVN: $7.41)
Brand notoriety: ALGS and ARVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 29% vs. ARVN: 65%
Market capitalization -- ALGS: $34.59M vs. ARVN: $491.05M
ALGS [@Biotechnology] is valued at $34.59M. ARVN’s [@Biotechnology] market capitalization is $491.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green while ARVN’s FA Score has 0 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • ARVN’s FA Score: 0 green, 5 red.
According to our system of comparison, ALGS is a better buy in the long-term than ARVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 6 TA indicator(s) are bullish while ARVN’s TA Score has 4 bullish TA indicator(s).

  • ALGS’s TA Score: 6 bullish, 4 bearish.
  • ARVN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALGS is a better buy in the short-term than ARVN.

Price Growth

ALGS (@Biotechnology) experienced а +0.54% price change this week, while ARVN (@Biotechnology) price change was -2.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.69%. For the same industry, the average monthly price growth was -14.41%, and the average quarterly price growth was -1.73%.

Reported Earning Dates

ALGS is expected to report earnings on Nov 05, 2026.

ARVN is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ALGS
Daily Signal:
Gain/Loss:
ARVN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRCX347.497.39
+2.17%
Lam Research Corp
MOBI9.180.15
+1.66%
Mobia Medical Inc.
HIMS29.00-0.30
-1.02%
Hims & Hers Health
LVLU13.64-0.15
-1.09%
Lulu's Fashion Lounge Holdings Inc
FMC8.44-0.12
-1.40%
FMC Corp

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with ABCL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
+0.73%
ABCL - ALGS
44%
Loosely correlated
-1.22%
ARVN - ALGS
41%
Loosely correlated
-0.27%
XNCR - ALGS
39%
Loosely correlated
+0.28%
EDIT - ALGS
38%
Loosely correlated
+3.97%
TECX - ALGS
37%
Loosely correlated
-0.57%
More

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with BCYC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then BCYC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
-0.27%
BCYC - ARVN
46%
Loosely correlated
-5.06%
AXON - ARVN
46%
Loosely correlated
-2.10%
VCYT - ARVN
46%
Loosely correlated
+3.67%
OLMA - ARVN
45%
Loosely correlated
-0.54%
KURA - ARVN
45%
Loosely correlated
N/A
More